Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new platform revision entry (v3.6.5) has been added to the record history, replacing the previous v3.6.4. This indicates a software/UI update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:56:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page history shows the latest site revision as v3.6.4, replacing the previous v3.6.3, indicating a platform update.
    Difference
    0.1%
    Check dated 2026-07-25T12:46:47.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small platform update rather than a change to the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a minor platform update to the history-tracking interface rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The record history now shows that participant recruitment has ended and the study documentation has a new revision (v3.6.0), with the prior revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:18.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new page revision, v3.5.5, was added to the history and the previous revision, v3.5.4, was removed, reflecting an update to the record history.
    Difference
    0.1%
    Check dated 2026-06-05T09:18:54.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.